2024-02-07 08:19:04 ET
Summary
- Stryker is a leading medical technology company with a diversified product portfolio that targets orthopedic surgery amongst other end markets.
- Stryker is currently reaping the rewards of a decade of heavy investment (R&D and M&A), with growth picking up and margins set to follow.
- Stryker's bright prospects are gradually being priced into the stock, with the company's revenue multiple expanding over the past decade.
- Given Stryker's strong competitive position and the potential for long-term double-digit earnings growth, the company's valuation could continue to increase.
...
Read the full article on Seeking Alpha
For further details see:
Stryker: Rerating Higher